Skip to main content
. 2021 Dec 24;11(2):100594. doi: 10.1016/j.hlpt.2021.100594

Table 3.

Health Financing before and after the outbreak of the COVID-19 pandemic.

Italy Spain France Israel
Total general government expenditure (% GDP) [45] 48.6 (2019) 57.3 (2020) 42.1 (2019) 52.3 (2020) 55.4(p) (2019) 62.1(p) (2020) 39.9 (2019) 46.4 (2020)
Health expenditure (% GDP) [46, 47]* 8.7 (2019) 9.7 (2020) 9.3 (2019) NA 11.2 (2019) NA 7.6 (2019) 8.5 (2020)
Spending for inpatient and curative care (% GDP) [45, 46] 2.3 (2019) NA 2.3 (2019) NA 3 (2018) NA 1.7 (2019) 1.8 (2020)
Investments in health (annual public budget - (million)) [46, [48], [49], [50]] 113,810 (Euro) (2020 - pre pandemic) 117,407 (2020); 121,370 (2021) 115,458 (Euro) (2019) NA 260,247 (Euro)
(2019)
200,924 (Euro)
(2020);
260,247 (Euro)
(2021)
107,411 (NIS) (2019) 118,053 (NIS) (2020)
Investments in equipment (e.g. ambulance, ventilators, tests, etc.) (million) [28, 46, 50] 6,404 (Euro) (2019) \ 6,842 (Euro)(2020) 9,045 (Euro) (2019)
NA 41,994 (Euro)
(2020)
49,994 (Euro) (2020);
100,294 (Euro)
(2021)
4,201 (NIS)
(2019)
4,555 (NIS)
(2020)

Note: * The figures for the health expenditure as the% of the GDP are retrieved from the OECD database [47] for easiness of comparison across countries. In France the official report from the Ministry of Solidarity and Health reports that in 2019 the health expenditure was equal to 8.6% of the GDP, while in 2020 it was 9.1% [51]. (p): provisional.